nL-FLVC-001

N/A

Report date: 2024/08/23 20:00:42
NME

Base Information

Drug NamenL-FLVC-001
Drug Alias NamenL-FLVC-001
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRetinitis PigmentosaAtaxia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Colorado Denver
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Colorado Denver
Inactive CompaniesN/A
Active IndicationsRetinitis PigmentosaAtaxia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A